Search clinical trials for: skin-to-skin contact
Total 5462 results
-
Eli Lilly and CompanyBoehringer IngelheimCompletedFibromyalgiaArgentina, Australia, Brazil, Canada, Mexico, Poland, Taiwan
-
Eli Lilly and CompanyCompletedOvarian Neoplasms | Primary Peritoneal CancerSpain, Germany, Belgium, United Kingdom
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedVasomotor Symptoms | Endometrial SafetyUnited States
-
Eli Lilly and CompanyCompletedOsteoporosis, PostmenopausalCanada, United States
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CarcinomaUnited States
-
Eli Lilly and CompanyCompletedMalignant Pleural MesotheliomaJapan
-
Eli Lilly and CompanyCompleted
-
Cordis CorporationCompletedCoronary Artery Disease
-
Eli Lilly and CompanyApproved for marketingALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.MesotheliomaUnited States, Brazil, Egypt, Saudi Arabia
-
Eli Lilly and CompanyCompletedGrowth DisorderUnited States
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedSocial PhobiaUnited States
-
University of MelbourneClinical Vision Research Australia; Cooper CompaniesCompleted
-
POZENCompletedMigraine HeadachesUnited States
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyBoehringer IngelheimCompletedUrinary Incontinence, StressUnited Kingdom
-
Eli Lilly and CompanyBoehringer IngelheimCompletedUrinary Incontinence, StressFrance, Sweden, Netherlands, Spain, Germany, South Africa, Switzerland
-
Eli Lilly and CompanyCompletedGenital Neoplasms, Female | Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms | Pelvic NeoplasmsUnited States
-
Eli Lilly and CompanyCompletedDepression, BipolarUnited States, Puerto Rico
-
Eli Lilly and CompanyCompletedBreast NeoplasmsUnited States
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderGermany
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderGermany
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedBipolar DisorderHungary, Australia, Greece, Russian Federation
-
Eli Lilly and CompanyCompletedCarcinoma, Non-Small-Cell LungUnited States
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderCanada
-
Eli Lilly and CompanyBoehringer IngelheimCompletedUrinary Incontinence, StressUnited Kingdom
-
Eli Lilly and CompanyCompletedGastrointestinal NeoplasmsKorea, Republic of
-
Eli Lilly and CompanyCompletedCarcinoma, Small CellUnited States
-
Eli Lilly and CompanyBoehringer IngelheimCompletedStress Urinary IncontinenceUnited States, Canada
-
Eli Lilly and CompanyCompletedAdvanced Gastric CarcinomaItaly
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedCarcinoma, Non-Small Cell LungChina, Taiwan, Australia, Korea, Republic of, Egypt, Romania, India, Turkey
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedUrinary Stress IncontinenceUnited States, Slovenia, United Kingdom
-
Eli Lilly and CompanyCompletedCarcinoma, Non Small Cell LungUnited States
-
Eli Lilly and CompanyCompletedBreast Cancer | Neoplasm MetastasisRussian Federation
-
Eli Lilly and CompanyCompletedSchizophrenia | Schizoaffective DisorderUnited States
-
Eli Lilly and CompanyCompletedLung NeoplasmsUnited States
-
Eli Lilly and CompanyBoehringer IngelheimCompletedUrinary Stress IncontinenceUnited States, Netherlands
-
Eli Lilly and CompanyCompletedBipolar DisorderUnited States, Lithuania, Puerto Rico, Romania, Russian Federation
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CarcinomaArgentina, Brazil, Chile, Mexico
-
Eli Lilly and CompanyCompletedDepressive DisorderUnited States
-
Eli Lilly and CompanyBoehringer IngelheimCompletedDepressive Disorder, MajorBelgium, Germany, France, Slovakia, Czech Republic, Finland
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedPancreatic CancerUnited States